Cytos Biotechnology Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $33.6M

Cytos Biotechnology General Information

Description

Operator of a biopharmaceutical company focused on the development of targeted immunotherapies.

Contact Information

Website
www.cytos.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Wagistrasse 25
  • 8952 Schlieren
  • Switzerland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Acquirer
Kuros Biosciences
Vertical(s)
Life Sciences
Corporate Office
  • Wagistrasse 25
  • 8952 Schlieren
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytos Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 18-Jan-2016 $33.6M Completed Generating Revenue
6. PIPE 31-Oct-2013 Completed Generating Revenue
5. PIPE 21-Mar-2012 Completed Generating Revenue
4. IPO 29-Oct-2002 Completed Generating Revenue
3. Later Stage VC 23-Jan-2002 Completed Generating Revenue
2. Early Stage VC 25-Jul-2000 $30.4M $38.5M Completed Generating Revenue
1. Early Stage VC 01-Jan-1999 $8.1M $8.1M Completed Generating Revenue
To view Cytos Biotechnology’s complete valuation and funding history, request access »

Cytos Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company focused on the development of targeted immunotherapies.
Drug Discovery
Schlieren, Switzerland
13 As of 2015

South San Francisco, CA
 

Vancouver, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cytos Biotechnology Competitors (45)

One of Cytos Biotechnology’s 45 competitors is Sutro Biopharma, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sutro Biopharma Formerly VC-backed South San Francisco, CA
Zymeworks Formerly VC-backed Vancouver, Canada
aTyr Pharma Formerly VC-backed San Diego, CA
Capricor Therapeutics Formerly VC-backed San Diego, CA
Agenus Formerly VC-backed Lexington, MA
You’re viewing 5 of 45 competitors. Get the full list »

Cytos Biotechnology Patents

  • 443

    Total Documents Applications and Grants

  • Total Patents Families

  • 70

    Granted

  • 8

    Pending

  • Expiring in next 12 mo

Cytos Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2015024992-A2 Treatment of asthma Inactive 22-Aug-2013
WO-2015024992-A3 Treatment of asthma Inactive 22-Aug-2013
AU-2010294249-A1 Use of interleukin-1 beta mutein conjugates in the treatment of diabetes Inactive 10-Sep-2009
CA-2773426-A1 Use of interleukin-1 beta mutein conjugates in the treatment of diabetes Inactive 10-Sep-2009
EP-2475397-A1 Use of interleukin-1 beta mutein conjugates in the treatment of diabetes Inactive 10-Sep-2009 A61K39/385
To view Cytos Biotechnology’s complete patent history, request access »

Cytos Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cytos Biotechnology Former Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Abingworth Venture Capital Minority
Adamant Biomedical Investment Asset Manager Minority
Aisling Capital Venture Capital Minority
Alta Partners Venture Capital Minority
Amgen Corporation Minority
You’re viewing 5 of 18 investors. Get the full list »

Cytos Biotechnology Acquisitions (2)

Cytos Biotechnology’s most recent deal was a Reverse Merger with Kuros Biosciences. The deal was made on 20-Jan-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Kuros Biosciences 20-Jan-2016 Reverse Merger Surgical Devices
Asklia Holding 28-Oct-2002 Merger/Acquisition Personal Products
To view Cytos Biotechnology’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Cytos Biotechnology FAQs

  • When was Cytos Biotechnology founded?

    Cytos Biotechnology was founded in 1995.

  • Where is Cytos Biotechnology headquartered?

    Cytos Biotechnology is headquartered in Schlieren, Switzerland.

  • What is the size of Cytos Biotechnology?

    Cytos Biotechnology has 13 total employees.

  • What industry is Cytos Biotechnology in?

    Cytos Biotechnology’s primary industry is Drug Discovery.

  • Is Cytos Biotechnology a private or public company?

    Cytos Biotechnology is a Private company.

  • What is the current valuation of Cytos Biotechnology?

    The current valuation of Cytos Biotechnology is .

  • What is Cytos Biotechnology’s current revenue?

    The current revenue for Cytos Biotechnology is .

  • How much funding has Cytos Biotechnology raised over time?

    Cytos Biotechnology has raised $114M.

  • Who are Cytos Biotechnology’s investors?

    Abingworth, Adamant Biomedical Investment, Aisling Capital, Alta Partners, and Amgen are 5 of 18 investors who have invested in Cytos Biotechnology.

  • Who are Cytos Biotechnology’s competitors?

    Sutro Biopharma, Zymeworks, aTyr Pharma, Capricor Therapeutics, and Agenus are some of the 45 competitors of Cytos Biotechnology.

  • When was Cytos Biotechnology acquired?

    Cytos Biotechnology was acquired on 18-Jan-2016.

  • Who acquired Cytos Biotechnology?

    Cytos Biotechnology was acquired by Kuros Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process